Toggle navigation
Home
Search
Services
Blog
Contact
About
Apc-Targeting Vaccine for Prevention of Type I Diabetes
Escher, Alan
Loma Linda University, Loma Linda, CA, United States
Search grants from Alan Escher
Search grants from Loma Linda University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
(PQC3) Ethnicity-determined immune response and DCIS outcome
The Health Services Center, Inc. -Revolution Project
Animal Model for Generation of Periodontal Attachment
Experimental Autoimmune Colitis - Model Development
Myocardial and Vascular Factors in Heart Failure
Recently added grants:
Imaging the alpha7 nicotinic acetylcholine receptor in mild cognitive impairment
Cell decision underlying B-cell immune responses
Multi-omic studies of asthma severity in an African ancestry population
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
Optimization of efflux avoidance and inhibition for antibiotic development
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DK057113-01
Application #
6053435
Study Section
Special Emphasis Panel (ZRG1-IMS (03))
Program Officer
Harmon, Joan T
Project Start
1999-09-30
Project End
2001-08-31
Budget Start
1999-09-30
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Loma Linda University
Department
Microbiology/Immun/Virology
Type
Schools of Dentistry
DUNS #
City
Loma Linda
State
CA
Country
United States
Zip Code
92350
Related projects
NIH 2000
R21 DK
Apc-Targeting Vaccine for Prevention of Type I Diabetes
Escher, Alan / Loma Linda University
$164,000
NIH 1999
R21 DK
Apc-Targeting Vaccine for Prevention of Type I Diabetes
Escher, Alan / Loma Linda University
Comments
Be the first to comment on Alan Escher's grant